Corre Stephane
Known title: President, AS&ICIK: 0002098782
Associated companies
Transaction History
| CSTM | ▼ Sell | Open Market | 5,000 | $168K | 5/8/2026 | View on chart |
| CSTM | ▼ Sell | Open Market | 5,000 | $160K | 5/1/2026 | View on chart |
| CSTM | ▲ Buy | Grant | 7,293 | $0 | 3/12/2026 | View on chart |
| CSTM | ▼ Sell | Open Market | 1,500 | $39K | 3/10/2026 | View on chart |
| CSTM | ▲ Buy | Open Market | 8,026 | $0 | 3/9/2026 | View on chart |
| CSTM | ▼ Sell | Open Market | 3,000 | $74K | 2/27/2026 | View on chart |
| CSTM | ▼ Sell | Open Market | 3,200 | $82K | 2/25/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Barclays initiates coverage on Constellium with Equal-Weight rating
Barclays has started covering Constellium with an Equal-Weight rating and a $28 price target. This new analyst view comes as the company prepares to report its third-quarter results on October 28, 2026. While some analysts suggest the stock could see further gains, the new target is below the current average analyst estimate of $33.67.
Barclays initiates coverage on Constellium with Equal-Weight rating. Barclays has started covering Constellium with an Equal-Weight rating and a $28 price target. This new analyst view comes as the company prepares to report its third-quarter results on October 28, 2026. While some analysts suggest the stock could see further gains, the new target is below the current average analyst estimate of $33.67.